Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 20/20 | 0.63 |
| ▸ | PPARA | Q07869 | 15/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | PPARD | Q03181 | 5/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9098920 | 0.91 | PPARG (0.57) | PPARGPPARACYP3A4CYP2C9KCNH2 | |
| SCHEMBL7164855 | 0.91 | PPARG (0.62) | PPARGPPARAPPARD | |
| SCHEMBL9097885 | 0.91 | PPARG (0.53) | PPARGPPARACYP3A4CYP2C9KCNH2 | |
| SCHEMBL7162959 | 0.89 | PPARG (0.59) | PPARGPPARAPPARD | |
| SCHEMBL7162075 | 0.88 | PPARG (0.58) | PPARGPPARAPPARD | |
| SCHEMBL9097890 | 0.86 | PPARG (0.50) | PPARGPPARACYP3A4CYP2C9KCNH2 | |
| SCHEMBL9094305 | 0.86 | PPARG (0.59) | PPARGPPARACYP3A4CYP2C9KCNH2 | |
| SCHEMBL9097431 | 0.85 | PPARG (0.48) | PPARGPPARACYP3A4CYP2C9KCNH2 | |
| SCHEMBL7487592 | 0.84 | PPARG (0.47) | PPARGPPARACYP3A4CYP2C9KCNH2 | |
| SCHEMBL8795234 | 0.84 | FFAR1 (0.62) | PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6204277-B1 | TREATING DIABETES | JAPAN TOBACCO INC. (JP) | 2001-03-20 | — | — | US | disclosed |
| US-6160124-A | Method for treating or preventing arteriosclerosis | JAPAN TOBACCO INC. (JP) | 2000-12-12 | — | — | US | disclosed |
| US-6057343-A | HAVE SUPERIOR HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIONS AND ARE USEFUL FOR THE TREATMENT OF DIABETES AND THE COMPLICATIONS THEREOF, AS WELL AS THERAPEUTIC AGENTS FOR RELATED DISEASES SUCH AS HYPERLIPIDEMIA | JAPAN TOBACCO, INC. (JP) | 2000-05-02 | — | — | US | disclosed |
| US-6037359-A | ARTERIOSCLEROSIS PREVENTION; ANTIDIABETIC AGENTS; ANTILIPEMIC AND HYPOGLYCEMIC AGENTS | JAPAN TOBACCO, INC. (JP) | 2000-03-14 | — | — | US | disclosed |
| EP-0930299-A1 | PROPIONIC ACID DERIVATIVES AND APPLICATIONS THEREOF | Japan Tobacco Inc. (JP) | 1999-07-21 | — | — | EP | disclosed |
| EP-0684242-B1 | ISOXAZOLIDINEDIONE DERIVATIVE AND USE THEREOF | JAPAN TOBACCO INC (JP) | 1999-05-06 | — | — | EP | disclosed |
| US-5498621-A | Oxazolidinedione hypoglycemic agents | PFIZER INC. (US) | 1996-03-12 | — | — | US | disclosed |
| EP-0684242-A1 | ISOXAZOLIDINEDIONE DERIVATIVE AND USE THEREOF | JAPAN TOBACCO INC. (JP) | 1995-11-29 | — | — | EP | disclosed |
| EP-0428312-B1 | Oxazolidinedione hypoglycemic agents | PFIZER (US) | 1994-12-28 | — | — | EP | disclosed |
| WO-1991007107-A1 | OXAZOLIDINEDIONE HYPOGLYCEMIC AGENTS | PFIZER INC. (US) | 1991-05-30 | — | — | WO | disclosed |
| EP-0428312-A2 | Oxazolidinedione hypoglycemic agents | PFIZER INC. (US) | 1991-05-22 | — | — | EP | disclosed |